Diab with prolif diabetic rtnop with trctn dtch n-mcla, bi refers to diabetic retinopathy characterized by proliferative changes and tractional detachment in both eyes. This condition arises from chronic hyperglycemia associated with diabetes mellitus, leading to retinal ischemia and neovascularization. Accurate coding with ICD-10 Code E08.3533 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious complication.
ICD-10 Code E08.3533 represents diabetic retinopathy with proliferative changes and tractional detachment in both eyes. This condition is a complication of diabetes mellitus, specifically linked to prolonged hyperglycemia. The code should be used in clinical documentation and billing when a patient presents with symptoms of diabetic retinopathy, particularly when there is evidence of neovascularization and retinal detachment.
Diab with prolif diabetic rtnop with trctn dtch n-mcla, bi is a severe form of diabetic retinopathy that can lead to significant vision loss if not treated promptly. It is caused by the progression of diabetes mellitus, where high blood sugar levels damage the retinal blood vessels, leading to neovascularization and potential tractional retinal detachment. This condition necessitates immediate medical attention to prevent irreversible vision impairment.
In SOAP notes, ICD-10 Code E08.3533 is utilized to document the diagnosis of diabetic retinopathy with proliferative changes and tractional detachment. It plays a crucial role in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
ICD-10 Code E08.3533 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diabetic retinopathy with proliferative changes and tractional detachment. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of Diab with prolif diabetic rtnop with trctn dtch n-mcla, bi requires urgent intervention to prevent vision loss. Treatment options may include laser therapy, intravitreal injections, or surgical intervention.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code E08.3533 is critical for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 92002 | New patient eye examination, intermediate. |
| 67028 | Intravitreal injection of a pharmacologic agent. |
| 67228 | Laser treatment of retinal disease. |
| 99213 | Established patient office visit, level 3. |
Common Questions About Using ICD-10 Code E08.3533 for Diab with prolif diabetic rtnop with trctn dtch n-mcla, bi
What are the symptoms of diabetic retinopathy?
Symptoms of diabetic retinopathy may include blurred vision, floaters, dark spots, and sudden vision loss. Patients may not notice symptoms until the disease is advanced, making regular eye exams essential.
How is diabetic retinopathy treated?
Treatment options for diabetic retinopathy include laser therapy, intravitreal injections, and vitrectomy surgery, depending on the severity of the condition and the presence of complications.
When should ICD-10 Code E08.3533 be used?
ICD-10 Code E08.3533 should be used when a patient is diagnosed with proliferative diabetic retinopathy with tractional detachment in both eyes, particularly when there are clinical findings of neovascularization.
What is the importance of coding diabetic retinopathy accurately?
Accurate coding of diabetic retinopathy is crucial for appropriate treatment planning, reimbursement, and tracking of public health data related to diabetes complications.
Clinical Notes
SOAP notes
DAP notes
AI medical notes